Skip to content

Join Us
Members Area

Home
ASOI News
About Us
Events
Media Resources
Public Resources
Guidelines
Research

Publication Category: Medications

Evolving Role of Double and Triple Therapy With GLP-1 Receptor Agonists in Obesity and Cardiovascular Disease

Sedrak P, Verma R, Verma M, Connelly KA. Evolving Role of Double and Triple Therapy With GLP-1 Receptor Agonists in Obesity and Cardiovascular Disease The Canadian Journal of Cardiology

Factors influencing patients to choose one obesity treatment over another: a qualitative study

Craig HC, Alsaeed D, Al Ozairi E, Norris S, Holian J, Kennedy C, Heneghan H, McGillicuddy D, Farrell E, Hollmann E, Al-Najim W, le Roux CW. Factors influencing patients to choose one obesity treatment over another: a qualitative study International Journal of Obesity

Subgroup analysis by sex and baseline BMI in people with a BMI ?27kg/m2 in the phase 2 trial of survodutide, a glucagon/GLP-1 receptor dual agonist

le Roux CW, Steen O, Lucas KJ, Startseva E, Unseld A, Hussain SA, Hennige AM. Subgroup analysis by sex and baseline BMI in people with a BMI ?27kg/m2 in the phase 2 trial of survodutide, a glucagon/GLP-1 receptor dual agonist Diabetes, Obesity and Metabolism

Multifunctional incretin peptides in therapies for type 2 diabetes, obesity and associated co-morbidities

Bailey CJ, Flatt PR, Conlon JM. Multifunctional incretin peptides in therapies for type 2 diabetes, obesity and associated co-morbidities The Journal of Peptide Science
Insulin Resistance & Diabetes

Anti-obesity treatment preferences of healthcare providers and people living with obesity: A survey-based study

Le Roux CW, Koroleva A, Larsen S, Foot E. Anti-obesity treatment preferences of healthcare providers and people living with obesity: A survey-based study Clin Obes

Treatment of Obesity with Thyroid hormones in Europe. Data from the THESIS* Collaboration

Galofré JC, Díez JJ, Attanasio R, Nagy EV, Negro R, Papini E, Perros P, Žarković M, Akarsu E, Alevizaki M, Ayvaz G, Bednarczuk T, Beleslin BN, Berta E, Bodor M, Borissova AM, Boyanov M, Buffet C, Burlacu MC, Dobnig H, Fadeyev V, Field BCT, Fliers E, Führe Treatment of Obesity with Thyroid hormones in Europe. Data from the THESIS* Collaboration J Endocrinol Invest

Novel neural pathways targeted by GLP-1R agonists and bariatric surgery

Hankir MK, Lutz TA. Novel neural pathways targeted by GLP-1R agonists and bariatric surgery Pflugers Arch

Determinants of adherence to obesity medication: A narrative review

Sharma AM, Birney S, Crotty M, Finer N, Segal-Lieberman G, Vázquez-Velázquez V, Vrijens B. Determinants of adherence to obesity medication: A narrative review The Official Journal of the International Association for the Study of Obesity

Subgroup analysis by sex and baseline BMI in people with a BMI ≥27 kg/m(2) in the phase 2 trial of survodutide, a glucagon/GLP-1 receptor dual agonist

le Roux CW, Steen O, Lucas KJ, Startseva E, Unseld A, Hussain SA, Hennige AM. Subgroup analysis by sex and baseline BMI in people with a BMI ≥27 kg/m(2) in the phase 2 trial of survodutide, a glucagon/GLP-1 receptor dual agonist Diabetes Obes Metab

A Comprehensive Review of the Role of GLP-1 Agonists in Weight Management and Their Effect on Metabolic Parameters Such as Blood Glucose, Cholesterol, and Blood Pressure

Gul U, Aung T, Martin M, Farrukh DN, Shah PC, Lovely ZS, Marroquín León E, Alansaari M, Maini S, Fariduddin MM, Ullah A, Nazir Z. A Comprehensive Review of the Role of GLP-1 Agonists in Weight Management and Their Effect on Metabolic Parameters Such as Blood Glucose, Cholesterol, and Blood Pressure Cureus

Older posts

Newer posts

← Previous Page1 … Page7 Page8 Page9 … Page30 Next →

Search for:

Recent Posts

10th ASOI Annual Scientific Meeting 2026
9th ASOI Annual Conference – Registration now open!
Press Release for World Obesity Day 4th March 2024
ASOI and ICPO response to : Medical Council Communication: “Important medicine shortage information – Ozempic (semaglutide)”
Things to do in Dublin during ECO

ASOI

info@asoi.info

Home
ASOI News
About Us
Events
Media Resources
Public Resources
Guidelines
Research

Home
ASOI News
About Us
Events
Media Resources
Public Resources
Guidelines
Research

Privacy Policy
Site Map

©2026 ASOI